Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: Exelixis Inc., 3 years.
Exelixis Inc.
Director
Caris Life Sciences Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 29, 2026 | Caris Life Sciences Inc. | Grant or award | +1,600 | $15.62 | $24,992 |
| May 27, 2026 | Exelixis Inc. | Grant or award | +8,367 | — | — |
| May 7, 2026 | Exelixis Inc. | Open-market sale | −60,000 | $45.71 | $2,742,600 |
| Aug 11, 2025 | Caris Life Sciences Inc. | Option exercise | +125,000 | $2.44 | $305,000 |
| Aug 11, 2025 | Caris Life Sciences Inc. | Shares withheld for tax | −48,022 | $29.75 | $1,428,655 |
| Aug 11, 2025 | Caris Life Sciences Inc. | Shares withheld for tax | −91,495 | $29.75 | $2,721,976 |
| May 29, 2025 | Exelixis Inc. | Grant or award | +9,812 | — | — |
| May 16, 2025 | Exelixis Inc. | Option exercise | +20,634 | $19.77 | $407,934 |
| May 16, 2025 | Exelixis Inc. | Open-market sale | −20,634 | $45.99 | $948,958 |
| Feb 14, 2025 | Exelixis Inc. | Option exercise | +15,874 | $20.50 | $325,417 |
| Feb 14, 2025 | Exelixis Inc. | Open-market sale | −15,874 | $34.74 | $551,463 |
| Nov 1, 2024 | Exelixis Inc. | Open-market sale | −30,000 | $34.00 | $1,020,000 |
| Aug 8, 2024 | Exelixis Inc. | Open-market sale | −33,725 | $26.89 | $906,865 |
| May 31, 2024 | Exelixis Inc. | Grant or award | +18,838 | — | — |
| May 21, 2024 | Exelixis Inc. | Option exercise | +11,686 | $19.57 | $228,695 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.